THE ROSE CLINIC LIMITED

Company Registration Number:
09339000 (England and Wales)

Unaudited micro entity accounts for the year ended 31 March 2024

Period of accounts

Start date: 01 April 2023

End date: 31 March 2024

THE ROSE CLINIC LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2024

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

THE ROSE CLINIC LIMITED

Company Information

for the Period Ended 31 March 2024




Registered office: Town Mill
Town Mill Lane
Whitchurch
RG28 7LZ
Company Registration Number: 09339000 (England and Wales)

THE ROSE CLINIC LIMITED

Balance sheet

As at 31 March 2024


2024
£

2023
£
Fixed Assets: 4,793 965
Current assets: 2,819 2,319
Creditors: amounts falling due within one year: ( 4,749 ) ( 2,016 )
Net current assets (liabilities): ( 1,930 ) 303
Total assets less current liabilities: 2,863 1,268
Total net assets (liabilities): 2,863 1,268
Capital and reserves: 2,863 1,268

THE ROSE CLINIC LIMITED

Balance sheet continued

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 11 September 2024
And Signed On Behalf Of The Board By:

Name: Mrs E Bayliss
Status: Director

The notes form part of these financial statements

THE ROSE CLINIC LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2024

  • 1. Employee Information

    Average number of employees: 1

THE ROSE CLINIC LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2024

  • 2. Off balance sheet disclosure

    No